Seven Fleet Capital Management »

Abivax SA F shares owned by Seven Fleet Capital Management

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Seven Fleet Capital Management from 13F filings

Historical chart of Seven Fleet Capital Management investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Seven Fleet Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Seven Fleet Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.6k 12 134.83

More positions owned by Seven Fleet Capital Management

Cg Oncology (CGON)
Soleno Therapeutics (SLNO)
Revolution Medicines (RVMD)
Liquidia Corporation Com New (LQDA)
Compass Therapeutics (CMPX)
Exelixis (EXEL)
Axsome Therapeutics (AXSM)
Tyra Biosciences (TYRA)
Cogent Biosciences (COGT)
Tango Therapeutics (TNGX)
Xencor (XNCR)
Pharvaris N V (PHVS)
Terns Pharmaceuticals (TERN)
Belite Bio Sponsored Ads (BLTE)
Dyne Therapeutics (DYN)

View all positions for Seven Fleet Capital Management

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Darwin Global Management
Point72 Asset Management
Vestal Point Capital
Susquehanna International
Caligan Partners
FMR
Paradigm Biocapital Advisors
Cormorant Asset Management
ADAR1 Capital Management
Barclays
Millennium Management
Westfield Capital Management Company
Adage Capital Partners GP

View all funds holding Abivax SA F